Journal
CELL CHEMICAL BIOLOGY
Volume 30, Issue 11, Pages 1453-+Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2023.07.017
Keywords
-
Categories
Ask authors/readers for more resources
Orphan cytotoxins are small molecules with unknown or unclear mechanisms of action. Discovering the mechanisms of these compounds is crucial for biological research and new therapeutic drugs. By engineering cancer cell lines with inducible mismatch repair deficits, the accuracy and sensitivity of identifying resistance mutations have been improved.
Orphan cytotoxins are small molecules for which the mechanism of action (MoA) is either unknown or ambiguous. Unveiling the mechanism of these compounds may lead to useful tools for biological investigation and new therapeutic leads. In selected cases, the DNA mismatch repair-deficient colorectal cancer cell line, HCT116, has been used as a tool in forward genetic screens to identify compound-resistant mutations, which have ultimately led to target identification. To expand the utility of this approach, we engineered cancer cell lines with inducible mismatch repair deficits, thus providing temporal control over mutagenesis. By screening for compound resistance phenotypes in cells with low or high rates of mutagenesis, we increased both the specificity and sensitivity of identifying resistance mutations. Using this inducible mutagenesis system, we implicate targets for multiple orphan cytotoxins, including a natural product and compounds emerging from a high-throughput screen, thus providing a robust tool for future MoA studies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available